Drugs / BPI-3016
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03188848 | May 2017 → Jul 2019 | — | Betta Pharmaceuticals Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BPI-3016 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03188848 ↗ |
| Route | Subcutaneous | “subcutaneously injected BPI-3016” NCT03188848 ↗ |